State Key Laboratory of Food Nutrition and Safety, Key Laboratory of Food Nutrition and Safety, Ministry of Education, College of Food Engineering and Biotechnology, Tianjin University of Science and Technology, Tianjin, 300457, China.
Food Funct. 2019 Aug 1;10(8):4792-4801. doi: 10.1039/c9fo00201d. Epub 2019 Jul 17.
The immunoregulatory effect of a novel Craterellus cornucopioides polysaccharide (CCP) with a triple-helix structure on immunosuppressive BALB/c mice models was investigated; moreover, the immune response of BALB/c mice models in the preventive and therapeutic treatment groups treated with CCP was explored, and its molecular mechanism was elucidated. It was found that the BALB/c mice models in the preventive groups treated with CCP (120 and 240 mg kg d) had better immunoregulatory activity. The spleen and thymus weight indices of the BALB/c mice models were significantly increased, and the histopathological analysis indicated a protective function of CCP against the immunosuppression induced by cyclophosphamide (CTX). Moreover, CCP displayed definite and clear synergistic effects on the T- or B-lymphocyte proliferation induced by ConA or LPS, respectively, promoted the natural killer (NK) cell activity and significantly increased phagocytic activity to activate peritoneal macrophages in immunosuppressive mice. The western blot and quantitative real-time polymerase chain reaction (qRT-PCR) results provided comprehensive evidence that CCP could upregulate the protein expression of the G-protein-coupled cell membrane receptor TLR4 and the production of its downstream protein kinases (TRAF6, TK1, p-IKKα/β and NF-κB p50); this, in turn, enhanced the production of cytokines (IL-2, IL-6, TNF-α and IFN-α) through both preventive and therapeutic treatments via regulation of the TLR4-NFκB pathway in the peritoneal macrophage of immunosuppressive mice.
研究了具有三螺旋结构的新型头状秃马勃多糖(CCP)对免疫抑制 BALB/c 小鼠模型的免疫调节作用;此外,还探讨了预防性和治疗性治疗组 BALB/c 小鼠模型的免疫反应,并阐明了其分子机制。结果发现,预防性给予 CCP(120 和 240 mg/kg/d)的 BALB/c 小鼠模型具有更好的免疫调节活性。BALB/c 小鼠模型的脾和胸腺重量指数显著增加,组织病理学分析表明 CCP 对环磷酰胺(CTX)诱导的免疫抑制具有保护作用。此外,CCP 对 ConA 或 LPS 诱导的 T 或 B 淋巴细胞增殖具有明确而清晰的协同作用,分别促进自然杀伤(NK)细胞活性,并显著增加吞噬活性以激活免疫抑制小鼠的腹腔巨噬细胞。Western blot 和定量实时聚合酶链反应(qRT-PCR)结果提供了全面的证据,表明 CCP 可以上调 G 蛋白偶联细胞膜受体 TLR4 的蛋白表达及其下游蛋白激酶(TRAF6、TK1、p-IKKα/β 和 NF-κB p50)的产生;这反过来又通过调节 TLR4-NFκB 通路增强了细胞因子(IL-2、IL-6、TNF-α和 IFN-α)的产生,通过预防性和治疗性治疗免疫抑制小鼠的腹腔巨噬细胞。